Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CellCarta, a global provider of precision medicine services, has announced the acquisition of Reveal Biosciences.
read more
Thursday, October 14, 2021
Avid Bioservices, a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, ...
read more
Wednesday, February 13, 2013
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug ...
read more
The lawsuit was filed in response to an Abbreviated New Drug Application, or ANDA, filed by Actavis. In its application, Actavis seeks to market and sell generic versions of the currently approved doses of Contrave®.
read more
Lipella Pharmaceuticals has re-signed its manufacturing collaboration agreement with Cook MyoSite to support Chemistry, Manufacturing and Control (CMC) documentation supporting their clinical products LP-10 and LP-310.
read more
Tuesday, February 24, 2026
Avid Bioservices announced the grand opening of its new Early Phase Center of Excellence, a state-of-the-art 78,000 square foot facility located in Costa Mesa, California.
read more
Thursday, December 19, 2019
Sartorius and the German Research Center for Artificial Intelligence (DFKI) have established the Sartorius AI Lab (SAIL) research laboratory.
read more
Monday, February 08, 2021
Xylyx Bio and Cell&Soft announced positive preliminary results, reaching a key milestone in their partnership to develop more physiologically relevant in vitro cellular models for cell-based assays in oncology.
read more
Wednesday, October 17, 2018
BioMarin announced the company earned $15 million in milestone payments from Pfizer.
read more
Signant Health will provide expert insights at the forthcoming DIA Global Annual Meeting in San Diego, CA June 23-27, 2019.
read more
Wednesday, September 18, 2019
SGS has announced the appointment of Steven Thys as its Director of Global Clinical Operations.
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies, has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway...
read more
Monday, November 21, 2016
Halozyme Therapeutics announced that AbbVie has discontinued a development program using the Halozyme ENHANZE™ platform technology and the tumor necrosis factor alpha (TNF-alpha) target following completion of a phase 1 study in which the target ...
read more
Tuesday, December 27, 2016
Eurofins Scientific has acquired ASL Análises Ambientais, one of the leading environment testing service providers in Brazil.
read more